CCIA
CBPO

Campbell & Co Investment Adviser’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Campbell & Co Investment Adviser’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,200
Closed -$225K – 515
2020
Q2 		$225K Buy
+2,200
New +$235K 0.28% 182

Other funds holding CBPO

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $54B AUM 23.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Campbell & Co Investment Adviser's CBPO Position: Q3 2020 in Review

Campbell & Co Investment Adviser sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2020, closing a stake of 2,200 shares — an estimated $225K sold.

Campbell & Co Investment Adviser first reported a position in CBPO in Q2 2020 and held it in 1 quarter. The position peaked at $225K in Q2 2020. 87 funds tracked by Wall St. Rank hold CBPO as of Q3 2020.

  • Campbell & Co Investment Adviser reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2020 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 2,200 China Biologic Products Holdings, Inc. shares in Q3 2020, an estimated $225K.
  • Campbell & Co Investment Adviser first reported a position in China Biologic Products Holdings, Inc. in Q2 2020 and held it in 1 quarter.
  • Campbell & Co Investment Adviser's China Biologic Products Holdings, Inc. position peaked at $225K in Q2 2020.
  • 87 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2020.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2020, filed 15 Oct 2020.